Rhythm Pharmaceuticals, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Rhythm Pharmaceuticals will hold its annual stockholders meeting virtually on June 24, 2025, to vote on director elections, auditor ratification, executive compensation, officer exculpation, and meeting adjournment if needed.
NASDAQ
Rhythm Pharmaceuticals is holding its annual meeting on June 24, 2025, to vote on director elections, auditor ratification, executive compensation, officer exculpation, and potential meeting adjournment.
NASDAQ
Rhythm Pharmaceuticals will hold its annual stockholders meeting virtually on September 18, 2024, to vote on director elections, auditor ratification, executive compensation, and reapproval of the equity incentive plan.
NASDAQ
Rhythm Pharmaceuticals is holding its Annual Meeting of Stockholders on September 18, 2024, to vote on key proposals including the election of directors, ratification of the independent auditor, executive compensation, and reapproval of the 2017 Equity Incentive Plan.
NASDAQ
Rhythm Pharmaceuticals has postponed its 2024 annual meeting to September 18, 2024, due to a technical error in the record date used for the broker search.
NASDAQ
Rhythm Pharmaceuticals will hold its annual stockholders meeting virtually on June 18, 2024, to vote on director elections, auditor ratification, executive compensation, and reapproval of the equity incentive plan.
NASDAQ
Rhythm Pharmaceuticals will hold its annual stockholders meeting virtually on June 18, 2024, to vote on director elections, auditor ratification, executive compensation, and the reapproval of the 2017 Equity Incentive Plan.